InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by FIL Ltd. Officer active across 3 companies, notably Xilio Therapeutics, Inc.. Cumulatively, 3 disclosures have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
FIL Ltd is a declarant linked to Bicara Therapeutics Inc., Structure Therapeutics Inc. and Xilio Therapeutics, Inc. The record shows 4 filings in total, with sampled filings dated from 2021-10-28 to 2024-09-18, and no buy or sell amount indicated in this sample.